Lukas Biomedical Inc. (TPEX:6814)

Lukas Biomedical Revenue

Lukas Biomedical had revenue of 87.92M TWD in the half year ending June 30, 2025, a decrease of -23.06%. This brings the company's revenue in the last twelve months to 180.32M, down -16.12% year-over-year. In the year 2024, Lukas Biomedical had annual revenue of 189.83M, down -18.12%.

• Revenue (ttm): 180.32M
• Revenue Growth: -16.12%
• P/S Ratio: 7.20
• Revenue / Employee: 1.88M
• Employees: 96
• Market Cap: 1.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	189.83M	-42.01M	-18.12%
Dec 31, 2023	231.83M	47.05M	25.46%
Dec 31, 2022	184.79M	27.17M	17.24%
Dec 31, 2021	157.62M	-23.79M	-13.12%
Dec 31, 2020	181.41M	28.52M	18.65%